Last reviewed · How we verify

NCT03790371

Vaginal Misoprostol Before Intrauterine Contraceptive Device Insertion

Completed Phase 3 Last updated 31 December 2018
What this trial tests

Phase 3 trial testing Misoprostol in Contraception in 90 participants. Completed in 1 August 2016.

Timeline
1 October 2015
Primary endpoint
1 August 2016
1 August 2016

Quick facts

Lead sponsorAin Shams University
PhasePhase 3
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment90
Start date1 October 2015
Primary completion1 August 2016
Estimated completion1 August 2016
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 20 to 44, female only, with Contraception. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

the current study was conducted to assess efficacy of vaginal misoprostol before IUD insertion following previous insertion failure

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Misoprostol

Trials testing the same drug.

Other recruiting trials for Contraception

Currently open trials in the same condition.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03790371.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing